Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

The Flowr Corporation FLWPF OTC

Other OTC • Healthcare • Drug Manufacturers - Specialty & Generic • CA • USD

SharesGrow Score
17/100
0/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

The Flowr Corporation (FLWPF) is a Drug Manufacturers - Specialty & Generic company in the Healthcare sector, currently trading at $0.00. It has a SharesGrow Score of 16/100, indicating a weak investment profile with 0 out of 7 criteria passed.

Financials: revenue is $12M, +63.3%/yr average growth. Net income is $86M (loss), growing at -117.6%/yr. Net profit margin is -692.7% (negative). Gross margin is -78.2% (-67.4 pp trend).

Balance sheet: total debt is $34M against $27M equity (Debt-to-Equity (D/E) ratio 1.23, moderate). Current ratio is 0.99 (tight liquidity). Debt-to-assets is 38.7%. Total assets: $87M.

SharesGrow 7-Criteria breakdown: Value ?/100 (Fail), Growth 58/100 (Partial), Past 0/100 (Fail), Health 17/100 (Fail), Moat 0/100 (Fail), Future ?/100 (Fail), Income 10/100 (Fail).

FLWPF SharesGrow Score Overview

28/100
SharesGrow Score
Below average — proceed with caution
View full scorecard →
VALUE 0/100
Valuation — P/E, PEG, Forward PEG
GROWTH 58/100
Financials — average growth
PAST 0/100
strong — trend
HEALTH 17/100
Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is
MOAT 0/100
Gross margin is + market cap
FUTURE 0/100
Analyst outlook — as buy
INCOME 10/100
Net profit margin is
Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — FLWPF

—
VALUE N/A
N/A
No analyst coverage available for this stock.
~
GROWTH Partial
58/100
FLWPF: +63.3%/yr revenue is, -117.6%/yr Net income is average growth. mixed. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.
View details →
—
PAST N/A
N/A
No analyst coverage available for this stock.
✗
HEALTH Fail
17/100
Balance sheet FLWPF: Debt-to-Equity (D/E) ratio 1.23 (moderate), Current ratio is 0.99 (tight liquidity). Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.
View details →
—
MOAT N/A
N/A
No analyst coverage available for this stock.
—
FUTURE N/A
N/A
No analyst coverage available for this stock.
✗
INCOME Fail
10/100
FLWPF: Net profit margin is -692.7%. negative. Score: ≥30% = 100, ≥20% = 85, ≥15% = 70, ≥10% = 55, ≥5% = 45, ≥0% = 30, < 0 = 10.
View details →

Stock Chart & Stats

Market Data
52-Week Range0.000001-0.00001
Volume1M
Avg Volume (30D)509.53K
Market Cap$4.27K
Beta (1Y)1.18
Share Statistics
EPS (TTM)-0.23
Shares Outstanding$372.92M
IPO Date2021-01-08
CEOSteven Adam Klein
Financial Highlights & Ratios
Revenue (TTM)$12.35M
Gross Profit$-9.66M
EBITDA$-77.26M
Net Income$-85.53M
Operating Income$-30.73M
Total Cash$4.2M
Total Debt$33.73M
Net Debt$29.54M
Total Assets$87.06M
Price / Earnings (P/E)-0
Price / Sales (P/S)0
Analyst Forecast
Company Info
CountryCA
ExchangeOther OTC
CurrencyUSD
ISINCA34354X1087

Price Chart

Track all markets on TradingView
FLWPF
The Flowr Corporation ↗  ·  Other OTC
Healthcare • Drug Manufacturers - Specialty & Generic
0.00 52WK RANGE 0.00

People Also View

ESAIY
ESAIY
Eisai Co., Ltd.
$7.71
-1.66%
 ESALF
ESALF
Eisai Co., Ltd.
$30.00
+0.00%
 SHMN
SHMN
SOHM, Inc.
$0.00
+0.00%
 SILFF
SILFF
Silo Wellness Inc.
$0.01
+166.67%
 ELLXF
ELLXF
Elixinol Wellness Limited
$0.01
+112.92%
 SLGWF
SLGWF
SLANG Worldwide Inc.
$0.00
+47.62%
 MSMY
MSMY
MC Endeavors, Inc.
$0.00
-44.44%
 THCBF
THCBF
THC Biomed Intl Ltd.
$0.00
+0.00%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message